Related Experiment Video
Updated: Jun 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Epigenetic Factor MicroRNAs Likely Mediate Vaccine Protection Efficacy against Lymphomas in Response to Tumor Virus
Lei Zhang1,2, Qingmei Xie3, Shuang Chang4
1U.S. Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Athens, GA 30605, USA.
Abstract:
Epigenetic factors, including microRNAs (miRNAs), play an important role in affecting gene expression and, therefore, are involved in various biological processes including immunity protection against tumors. Marek's disease (MD) is a highly contagious disease of chickens caused by the MD virus (MDV). MD has been primarily controlled by vaccinations. MD vaccine efficacy might, in part, be dependent on modulations of a complex set of factors including host epigenetic factors. This study was designed to identify differentially expressed miRNAs in the primary lymphoid organ, bursae of Fabricius, in response to MD vaccination followed by MDV challenge in two genetically divergent inbred lines of White Leghorns. Small RNA sequencing and bioinformatic analyses of the small RNA sequence reads identified hundreds of miRNAs among all the treatment groups. A small portion of the identified miRNAs was differentially expressed within each of the four treatment groups, which were HVT or CVI988/Rispens vaccinated line 63-resistant birds and line 72-susceptible birds. A direct comparison between the resistant line 63 and susceptible line 72 groups vaccinated with HVT followed by MDV challenge identified five differentially expressed miRNAs. Gene Ontology analysis of the target genes of those five miRNAs revealed that those target genes, in addition to various GO terms, are involved in multiple signaling pathways including MAPK, TGF-β, ErbB, and EGFR1 signaling pathways. The general functions of those pathways reportedly play important roles in oncogenesis, anti-cancer immunity, cancer cell migration, and metastatic progression. Therefore, it is highly likely that those miRNAs may, in part, influence vaccine protection through the pathways.
Insights
This study identified specific microRNAs (miRNAs) in chickens that change after Marek's disease vaccination and virus challenge. These miRNAs may influence vaccine effectiveness by affecting cancer-related signaling pathways.
Area of Science:
- Animal Science
- Immunology
- Molecular Biology
Background:
- Epigenetic factors, like microRNAs (miRNAs), regulate gene expression and are crucial for biological processes, including anti-tumor immunity.
- Marek's disease (MD), a contagious chicken disease caused by the MD virus (MDV), is managed through vaccination, whose efficacy may involve host epigenetic modifications.
Purpose of the Study:
- To identify differentially expressed miRNAs in the bursae of Fabricius in response to MD vaccination and subsequent MDV challenge.
- To investigate the role of these miRNAs in vaccine efficacy by analyzing their target genes and associated signaling pathways in genetically divergent chicken lines.
Main Methods:
- Small RNA sequencing and bioinformatic analyses were performed on bursae of Fabricius from two inbred White Leghorn lines (resistant line 63 and susceptible line 72).
- Birds were subjected to vaccination (HVT or CVI988/Rispens) followed by MDV challenge.
- Differential miRNA expression analysis and Gene Ontology (GO) analysis of target genes were conducted.
Main Results:
- Hundreds of miRNAs were identified, with a subset showing differential expression across treatment groups.
- A direct comparison between vaccinated resistant and susceptible lines revealed five differentially expressed miRNAs.
- GO analysis indicated that the target genes of these five miRNAs are involved in critical signaling pathways such as MAPK, TGF-β, ErbB, and EGFR1.
Conclusions:
- The identified differentially expressed miRNAs likely play a role in modulating vaccine protection against Marek's disease.
- These miRNAs may influence anti-cancer immunity and disease progression through their involvement in key oncogenic and anti-cancer signaling pathways.
Related Concept Videos
MicroRNAs
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

